Login / Signup

Siponimod from fingolimod direct switch in patients transitioning in secondary progressive multiple sclerosis: A single center case series.

Antonella BiancoTommaso GuerraFrancesca CaputoDamiano PaolicelliPietro Iaffaldano
Published in: Clinical neurology and neurosurgery (2024)
Real-world results from our cohort demonstrated that the direct switch from FIN to SIP in patients transitioning in SP course is associated with clinical and disability progression stability, with a favorable safety profile.
Keyphrases
  • multiple sclerosis
  • end stage renal disease
  • ejection fraction
  • chronic kidney disease
  • peritoneal dialysis
  • prognostic factors
  • patient reported outcomes